Olarinoye-Akorede Sefiya A, Yunusa Garba H, Aliyu Halima, Hamidu Ahmed U
Department of Radiology, Ahmadu Bello University Teaching Hospital, Nigeria.
Department of Radiology, Unman Dan-Fodiyo University, Nigeria.
SA J Radiol. 2018 Nov 1;22(2):1315. doi: 10.4102/sajr.v22i2.1315. eCollection 2018.
Probably benign breast lesions in the Breast Imaging Reporting and Data Systems (BI-RADS 3) constitute a crucial category and a considerable number of all palpable breast masses. Local data concerning the outcome of such lesions in the Nigerian environment is almost non-existent.
The goal of this article is to report the frequency, outcome and malignancy detection rate among palpable breast masses that were categorised on ultrasound as BI-RADS category 3 (probably benign) according to the American College of Radiology (ACR).
Between January 2015 and July 2017, 603 patients had diagnostic whole-breast ultrasound scans. There were 277 women who complained of palpable breast masses, of whom 151 women were diagnosed as having BI-RADS 3 lesions. The final lesion outcome was determined by either biopsy or ultrasound follow-up examination for a total of 2 years. All data were recorded and analysed with Statistical Package for the Social Sciences (SPSS) version 20 (Chicago, USA).
The frequency of BI-RADS category 3 lesions among all the women who underwent breast ultrasound was 25% (151/603); and 54% (151/277) in patients with palpable breast masses. There were 25 patients who were excluded because of incomplete data or who were lost to follow-up. A total of 122 patients had both ultrasound examination and histopathologic diagnosis, while only 4 were followed up for 2 years on ultrasound alone. Of the 122 women biopsied, 117 (95.9%) had benign histologic outcomes, and of the remaining 5, cancer was confirmed in 2 (1.6%), while the remaining 3 patients (2.5%) had lesions considered intermediate at histology (juvenile papillomatosis, borderline phylloides and atypical ductal hyperplasia). Three out of four patients who had ultrasound follow-up alone had stable lesions after 2 years, while one patient had complete resolution.
This study found a significantly high biopsy rate of 80% (122/151) for probably benign lesions but a low detection rate for malignancy (1.6%). Follow-up with imaging rather than biopsy for lesions sonographically described as probably benign, will reduce medical costs and unwarranted invasive procedures.
乳腺影像报告和数据系统(BI-RADS 3)中可能为良性的乳腺病变是一个关键类别,且在所有可触及的乳腺肿块中占相当比例。在尼日利亚环境下,关于此类病变转归的本地数据几乎不存在。
本文的目的是报告根据美国放射学会(ACR)超声分类为BI-RADS 3类(可能为良性)的可触及乳腺肿块的发生率、转归及恶性肿瘤检出率。
2015年1月至2017年7月期间,603例患者接受了全乳诊断性超声检查。有277例女性主诉可触及乳腺肿块,其中151例女性被诊断为BI-RADS 3类病变。最终病变转归通过活检或超声随访检查确定,共随访2年。所有数据均使用社会科学统计软件包(SPSS)20版(美国芝加哥)进行记录和分析。
在所有接受乳腺超声检查的女性中,BI-RADS 3类病变的发生率为25%(151/603);在有可触及乳腺肿块的患者中为54%(151/277)。有25例患者因数据不完整或失访而被排除。共有122例患者接受了超声检查和组织病理学诊断,而仅有4例仅接受了2年的超声随访。在122例接受活检的女性中,117例(95.9%)组织学结果为良性,其余5例中,2例(1.6%)确诊为癌症,其余3例患者(2.5%)组织学上为中间性病变(幼年性乳头状瘤病、交界性叶状肿瘤和非典型导管增生)。仅接受超声随访的4例患者中,3例在2年后病变稳定,1例完全消退。
本研究发现,可能为良性的病变活检率高达80%(122/151),但恶性肿瘤检出率低(1.6%)。对于超声描述为可能为良性的病变,采用影像学随访而非活检,将降低医疗成本和不必要的侵入性操作。